blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2611313

EP2611313 - METHOD AND PREPARATION FOR THE TREATMENT OR PREVENTION OF ANXIETY OR NEUROGENESIS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.07.2021
Database last updated on 26.07.2024
FormerExamination is in progress
Status updated on  27.10.2017
Most recent event   Tooltip30.07.2021Application deemed to be withdrawnpublished on 01.09.2021  [2021/35]
Applicant(s)For all designated states
N.V. Nutricia
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
[2013/28]
Inventor(s)01 / HOMBERG, Judith
Hegdambroek 2509
NL-6546 WN Nijmegen / NL
02 / KILIAAN, Amanda, Johanne
Praetoriumstraat 25
NL-6522 HN Nijmegen / NL
03 / BROERSEN, Ladislaus, Maria
Kneppelhoutstraat 27
NL-3532 EW Utrecht / NL
 [2013/28]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2013/28]
Application number, filing date10754601.203.09.2010
WO2010NL50558
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012030208
Date:08.03.2012
Language:EN
[2012/10]
Type: A1 Application with search report 
No.:EP2611313
Date:10.07.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2012 takes the place of the publication of the European patent application.
[2013/28]
Search report(s)International search report - published on:EP08.03.2012
ClassificationIPC:A23L1/30, A23L1/302, A23L1/305, A61K31/202, A61K31/23
[2013/28]
CPC:
A61K31/661 (EP,US); A61K31/202 (EP,RU,US); A23L33/12 (EP,US);
A23L33/15 (EP,US); A23L33/175 (EP,US); A23L33/40 (EP,US);
A61K31/20 (EP,US); A61K31/405 (EP,RU,US); A61K31/4415 (EP,RU,US);
A61K31/519 (EP,US); A61K31/6615 (RU); A61K31/675 (RU);
A61K31/685 (EP,RU,US); A61K45/06 (EP,US); A61P25/22 (EP);
A61P25/24 (EP); A23V2002/00 (EP,US); A61K2121/00 (RU);
A61K2300/00 (RU) (-)
C-Set:
A61K31/20, A61K2300/00 (US,EP);
A61K31/405, A61K2300/00 (US,EP);
A61K31/685, A61K2300/00 (US,EP);
A23V2002/00, A23V2200/322, A23V2250/161, A23V2250/1642, A23V2250/1852, A23V2250/1862, A23V2250/1868, A23V2250/187, A23V2250/1874, A23V2250/7052, A23V2250/7056, A23V2250/706 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2013/28]
TitleGerman:VERFAHREN UND ZUBEREITUNG FÜR DIE BEHANDLUNG ODER PRÄVENTION VON ANGSTZUSTÄNDEN ODER NEUROGENESE[2013/28]
English:METHOD AND PREPARATION FOR THE TREATMENT OR PREVENTION OF ANXIETY OR NEUROGENESIS[2013/28]
French:PROCÉDÉ ET PRÉPARATION POUR LE TRAITEMENT OU LA PRÉVENTION DE L'ANXIÉTÉ OU POUR LA RÉGULATION DE LA NEUROGENÈSE[2013/28]
Entry into regional phase01.03.2013National basic fee paid 
01.03.2013Designation fee(s) paid 
01.03.2013Examination fee paid 
Examination procedure03.07.2012Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.03.2013Amendment by applicant (claims and/or description)
01.03.2013Examination requested  [2013/28]
31.10.2017Despatch of a communication from the examining division (Time limit: M04)
08.01.2018Reply to a communication from the examining division
01.04.2021Application deemed to be withdrawn, date of legal effect  [2021/35]
23.04.2021Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2021/35]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  31.10.2017
Fees paidRenewal fee
15.03.2013Renewal fee patent year 03
13.08.2013Renewal fee patent year 04
20.08.2014Renewal fee patent year 05
21.08.2015Renewal fee patent year 06
15.08.2016Renewal fee patent year 07
21.08.2017Renewal fee patent year 08
13.08.2018Renewal fee patent year 09
17.09.2019Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
30.09.202011   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]DE2824362  (KLOSA JOSEF DIPL CHEM DR RER N) [X] 1-4 * page 2, paragraph 1 - page 3, paragraph 1; example 1 * [I] 5-10;
 [XI]US2002182196  (MCCLEARY EDWARD LARRY [US]) [X] 2-8 * paragraphs [0001] , [0 45] , [0177] * [I] 1,9,10;
 [XDI]EP1275399  (NUTRICIA NV [NL]) [XD] 1,3-8 * paragraph [0031]; examples 1-3; claims 1-24 * [I] 2,9,10;
 [XI]WO03003981  (VITAL BASICS INC [US], et al) [X] 1-8 * claim 1; table 1 * [I] 9,10;
 [XI]WO03041701  (NUTRICIA NV [NL], et al) [X] 1-8 * page 1, lines 15-22; claim 12; table 1 * [I] 9,10;
 [XI]WO2004062389  (HUNZA DI PISTOLESI ELVIRA & C [IT], et al) [X] 1,3-8 * page 9, line 16 - page 10, line 2; example 2 * [I] 2,9,10;
 [XI]US2005002992  (MCCLEARY EDWARD LARRY [US], et al) [X] 2-8 * tables 10,11 * [I] 1,9,10;
 [XI]WO2005112654  (PBM PHARMACEUTICALS INC [US], et al) [X] 1,3-7 * page 3, paragraph 2; example 1 * [I] 2,8-10;
 [XI]DE202007000949U  (VOGEL LUKAS [DE], et al) [X] 1,3-8 * paragraphs [0017] - [0023]; claims 4,7,9,13 * [I] 2,9,10;
 [XI]EP1800675  (NUTRICIA NV [NL]) [X] 1,3-8 * paragraph [0022]; examples 1,2; claim 8 * [I] 2,9,10;
 [XI]US2009110674  (LOIZOU NICOS C [US]) [X] 1-8 * paragraphs [0023] , [0045] , [0253]; claims 1,7; table 1 * [I] 9,10;
 [XDI]  - BROERSEN L M ET AL, "A multi-nutrient intervention but not omega-3 PUFA-rich fish oil by itself reduces depression relevant to Alzheimer's disease", EUROPEAN JOURNAL OF NEUROLOGY : THE OFFICIAL JOURNAL OF THE EUROPEAN FEDERATION OF NEUROLOGICAL SOCIETIES; 12TH CONGRESS OF THE EUROPEAN-FEDERATION-OF-NEUROLOGICAL-SOCIETIES MADRID, SPAIN; AUGUST 23 20080801 OXFORD [U.A.] : WILEY-BLACKWELL, vol. 15, no. s3, doi:DOI:10.1111/J.1468-1331.2008.02286, ISSN 1468-1331, (20080801), page 226, (20080812), XP008136890 [XD] 1,3-8 * paragraph [P2019] * [I] 2,9,10

DOI:   http://dx.doi.org/10.1111/j.1468-1331.2008.02286
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.